NCBiotech Funding Programs
Among the many obstacles between idea and market in life science product development, the most daunting is securing capital.
NCBiotech offers several funding programs designed to fill gaps in technology development and company growth. These funds help university researchers and companies conduct critical studies and reach significant development milestones that enable them to attract follow-on funding.
Company Funding provides $75,000 to $500,000 to innovative North Carolina life science companies.
University Technology Development Funding distributes grants to N.C. universities to advance great innovations with compelling commercial potential.
Awardee Resources - Forms and other resources for recipients of NCBiotech funding.
Event and Meeting Grants – NCBiotech provides grants to help N.C.’s non-profit organizations stage professional conferences, workshops or similar events across the state.
Past Awards - The past five years of our awards are searchable on this page. Since its founding nearly 35 years ago, NCBiotech has distributed almost 3,000 awards totaling more than $150 million.
Other Funding Resources - Scan our lists of research funding organizations, funding for education projects, and angel and VC funders.
NCBiotech Funding Continuum

Filter by
Grant
Research and Tech
Maximum Award: $20,000
FY2021 Deadlines:
Cycle 1
Wednesday, August 12, 2020 (noon)
Targeted Solicitation (closed)
Cycle 2
Wednesday, November 11, 2020 (noon)
Targeted Solicitation (see guidelines)
Cycle 3
Wednesday, March 10, 2021 (noon)
Targeted Solicitation (see guidelines)
Grant
Research and Tech
Maximum Award: $150,000
FY2021 Deadline:
Wednesday, October 14, 2020 (noon)
Grant
Research and Tech
Applications are not being accepted for this program at this time.
Loan
Business Loans
Maximum Award: $250,000
Deadline: Quarterly
Loan
Business Loans
Maximum Award: $500,000
Deadline: Quarterly
Grant
Research and Tech
Maximum Award: $100,000 (FY20 amount)
FY2021 Deadlines:
Cycle 1
Wednesday, August 26, 2020 (noon)
Cycle 2
Wednesday, February 10, 2021 (noon)